SCHEMBL2011739

SCHEMBL2011739

NCCc1cc(Cl)c2cccnc2c1N1CCCC(CO)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 3/20 0.43
MAPT P10636 5/20 0.41
KDM4E B2RXH2 4/20 0.41
LMNA P02545 4/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
TDP1 Q9NUW8 4/20 0.41
HTT P42858 4/20 0.41
ALDH1A1 P00352 3/20 0.41
MPI P34949 2/20 0.41
RAB9A P51151 5/20 0.39
NPSR1 Q6W5P4 5/20 0.39
KMT2A Q03164 4/20 0.39
MAPK1 P28482 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
USP2 O75604 1/20 0.39
NOD2 Q9HC29 1/20 0.39
NPC1 O15118 4/20 0.39
MAP4K4 O95819 1/20 0.38
HSP90AA1 P07900 2/20 0.38
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2014591 0.88 METAP2 (0.44) METAP2MAPTKDM4ELMNASMN1; SMN2
SCHEMBL2014589 0.88 METAP2 (0.44) METAP2MAPTKDM4ELMNASMN1; SMN2
SCHEMBL2018508 0.88 KDM4E (0.43) METAP2MAPTKDM4ELMNASMN1; SMN2
SCHEMBL2054343 0.86 METAP2 (0.42) METAP2MAPTKDM4ELMNASMN1; SMN2
SCHEMBL2015476 0.85 METAP2 (0.42) METAP2MAPTKDM4ELMNASMN1; SMN2
SCHEMBL2011479 0.84 METAP2 (0.43) METAP2MAPTKDM4ELMNASMN1; SMN2
SCHEMBL2011476 0.84 METAP2 (0.43) METAP2MAPTKDM4ELMNASMN1; SMN2
SCHEMBL2012021 0.83 METAP2 (0.40) METAP2MAPTKDM4ELMNASMN1; SMN2
SCHEMBL2015791 0.83 METAP2 (0.42) METAP2MAPTKDM4ELMNASMN1; SMN2
SCHEMBL2011741 0.83 METAP2 (0.42) METAP2MAPTKDM4ELMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011075630-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2011-06-23 WO disclosed